Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ASPIRO

  • FDA Approval
  • Jan. 20, 2023, 12:42 UTC
  • 24
  • 0 comments

FDA approve LACOSAMIDE

Comment Full text

JANSSEN BIOTECH

  • FDA Approval
  • Jan. 20, 2023, 12:42 UTC
  • 29
  • 0 comments

FDA approve DARATUMUMAB

Comment Full text

SEAGEN

  • FDA Approval
  • Jan. 20, 2023, 12:42 UTC
  • 23
  • 0 comments

FDA approve TUCATINIB

Comment Full text

BEIGENE

  • FDA Approval
  • Jan. 20, 2023, 12:42 UTC
  • 25
  • 0 comments

FDA approve ZANUBRUTINIB

Comment Full text

KRAMER

  • FDA Approval
  • Jan. 20, 2023, 12:42 UTC
  • 24
  • 0 comments

FDA approve KETOCONAZOLE

Comment Full text

MSN

  • FDA Approval
  • Jan. 20, 2023, 12:42 UTC
  • 24
  • 0 comments

FDA approve OLMESARTAN MEDOXOMIL

Comment Full text

PRASCO

  • FDA Approval
  • Jan. 20, 2023, 12:42 UTC
  • 26
  • 0 comments

FDA approve MIRTAZAPINE

Comment Full text

RUBICON

  • FDA Approval
  • Jan. 20, 2023, 12:42 UTC
  • 27
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

ASCENT PHARMS INC

  • FDA Approval
  • Jan. 20, 2023, 12:42 UTC
  • 33
  • 0 comments

FDA approve LEVOTHYROXINE SODIUM

Comment Full text

LUPIN LTD

  • FDA Approval
  • Jan. 20, 2023, 01:55 UTC
  • 28
  • 0 comments

FDA approve DOLUTEGRAVIR;EMTRICITABINE;TENOFOVIR ALAFENAMIDE

Comment Full text
  • Previous
  • 895
  • 896
  • 897
  • 898
  • 899
  • Next

Search

News categories

  • Technical Exchange News(12253)
  • Event(6229)
  • SEC News(265343)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(154895)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin